Special Considerations in the Management of HIV-Infected Adolescents

  • Author: Lisa Hightow-Weidman, MD, MPH (More Info)
  • Section Editor: Judith S. Currier, MD, MSc
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 11/4/21 (What's New)

Summary

  • Transition practices relating to YLHA are shaped by patient demographics, requirements for medication adherence, risks of antiretroviral drug resistance, and societal, family, and patient attitudes toward HIV/AIDS
  • Research on transitional care for YLHA is limited[Rusley 2009; Miles 2004; Wiener 2007; Wagner 2008; Vijayan 2009]

Action required

Keywords: Pediatric/Adolescent Patients, Pediatric/Adolescent Patients

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.